 | |
| Clinical data | |
|---|---|
| Trade names | Andol, Fherbolico, Megabolin, Megabolin Retar, Pluropon, Proteron-Depot, Sanabolicum |
| Other names | Nandrolone cyclohexanepropionate; 19-Nortestosterone 17β-(3-cyclohexyl)propionate; NTHCP |
| Routes of administration | Intramuscular injection |
| Drug class | Androgen; Anabolic steroid; Androgen ester; Progestogen |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.011.831  |
| Chemical and physical data | |
| Formula | C27H40O3 |
| Molar mass | 412.614 g·mol |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
Nandrolone cyclohexylpropionate (BANTooltip British Approved Name, JANTooltip Japanese Accepted Name) (brand names Andol, Fherbolico, Megabolin, Megabolin Retar, Pluropon, Proteron-Depot, Sanabolicum), or nandrolone cyclohexanepropionate, also known as 19-nortestosterone 17β-(3-cyclohexyl)propionate (NTHCP), is a synthetic androgen and anabolic steroid and a nandrolone ester that is or has been marketed in Spain, Austria, and Israel.
| Compound | PRTooltip Progesterone receptor | ARTooltip Androgen receptor | ERTooltip Estrogen receptor | GRTooltip Glucocorticoid receptor | MRTooltip Mineralocorticoid receptor | SHBGTooltip Sex hormone-binding globulin | CBGTooltip Corticosteroid-binding globulin |
|---|---|---|---|---|---|---|---|
| Nandrolone | 20 | 154–155 | <0.1 | 0.5 | 1.6 | 1–16 | 0.1 |
| Testosterone | 1.0–1.2 | 100 | <0.1 | 0.17 | 0.9 | 19–82 | 3–8 |
| Estradiol | 2.6 | 7.9 | 100 | 0.6 | 0.13 | 8.7–12 | <0.1 |
| Notes: Values are percentages (%). Reference ligands (100%) were progesterone for the PRTooltip progesterone receptor, testosterone for the ARTooltip androgen receptor, estradiol for the ERTooltip estrogen receptor, dexamethasone for the GRTooltip glucocorticoid receptor, aldosterone for the MRTooltip mineralocorticoid receptor, dihydrotestosterone for SHBGTooltip sex hormone-binding globulin, and cortisol for CBGTooltip corticosteroid-binding globulin. Sources: See template. | |||||||
See also
References
- Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 660–. ISBN 978-1-4757-2085-3.
- Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 716–717. ISBN 978-3-88763-075-1.
- Mozayani A, Raymon L (15 October 2003). Handbook of Drug Interactions: A Clinical and Forensic Guide. Springer Science & Business Media. pp. 501–. ISBN 978-1-59259-654-6.
| Progestogens and antiprogestogens | |||||
|---|---|---|---|---|---|
| Progestogens (and progestins) |
| ||||
| Antiprogestogens |
| ||||
| |||||
| Androgen receptor modulators | |||||||
|---|---|---|---|---|---|---|---|
| ARTooltip Androgen receptor |
| ||||||
| GPRC6A |
| ||||||
| Progesterone receptor modulators | |||||||
|---|---|---|---|---|---|---|---|
| PRTooltip Progesterone receptor |
| ||||||
| mPRTooltip Membrane progesterone receptor (PAQRTooltip Progestin and adipoQ receptor) |
| ||||||
 | This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it. |
 | This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it. |
 | This article about a steroid is a stub. You can help Misplaced Pages by expanding it. |